‘Analysts had been optimistic about the potential of using RFID technology to track pharmaceuticals, thereby curbing theft and counterfeiting while encouraging supply chain efficiency.
In fact, last year technology market research firm ABI Research estimated that the shipments of life sciences RFID transponders would more than triple by the end of this year.
But new state legislation has thrown a wrench into the mechanics of these predications; recently ABI dramatically re-evaluated their expectations. Now they anticipate that only about 10 prescription drugs will be tagged with RFID transponders on a large scale this year.’
Read more at Pharmaceutical RFID Adoption Stalls
- Sigma Pharmaceuticals year profit rises 27 pct
- South African citizens cheap drug guinea pigs
- Two drugs test victims face a year in coma
- Can drug companies improve their reputation?
- Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
- Pfizer’s Forecast Disappoints
- Pharmaceutical RFID Adoption Stalls
- Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients
- GlaxoSmithKline unveils best results since merger
- Pfizer Sues Teva, Sandoz Over Zithromax